Recent court decisions could make it more difficult for scientists to individually secure usage rights for research involving the study of human biological materials, as patients and clinicians have begun to question exactly what is granted—and to whom it is granted—when a patient signs an informed consent agreement.
Read the complete article by clicking on the link below.
Related Insights
August 7, 2025
Manufacturing Industry Advisor
Tariffs and Your Contracts: Why do pricing and tax provisions matter?
President Trump’s shakeup of U.S. trade policy with its approach to tariffs is costing companies billions of dollars.
August 7, 2025
Foley Viewpoints
USPTO Addresses Reports of New Patent Fee Structure
In a recent webinar hosted by the Licensing Executives Society, U.S. Patent and Trademark Office acting Director Coke Morgan Stewart…
August 7, 2025
Manufacturing Industry Advisor
Tariffs and Your Contracts: Introduction
The rise of President Trumps’ tariffs in 2025 has brought uncertainty to the profitability of product sales and has thrown a wrench in previously stable supply relationships.